CKD Corporation FY2027 Q1 Earnings Report

Quick View

Executive Summary

The company achieved highly profitable growth, with both revenue and profit increasing and the growth rate of operating income significantly exceeding that of revenue. Revenue was ¥49.11B (up +35.5% YoY), operating income was ¥8.03B (up +112.9%), ordinary income was ¥8.24B (up +122.5%), and net income was ¥5.69B (up +129.6%). Expanding demand in the core Machine segment, together with operating leverage from improved gross margin and a lower SG&A ratio, drove the increase in profit growth.

Factors Affecting Performance

【Revenue】Revenue increased to ¥49.11B, up +35.5% YoY. By segment, Machine accounted for the majority at ¥46.09B (93.8% composition ratio, YoY +45.4%) and led overall growth, while AutoMachine contracted to ¥3.04B (6.2% composition ratio, YoY -33.5%). Overall growth is therefore dependent on increased Machine volumes and an improved product mix.

【Profit and Loss】Operating income was ¥8.03B (YoY +112.9%), and the operating margin improved to 16.4% from 10.4% in the same period last year. Both the improvement in gross margin to 31.7% (approximately 29.1% in the prior year) and the decline in the SG&A ratio to 15.3% (approximately 18.7% in the prior year) contributed, with economies of scale taking effect. Ordinary income was ¥8.24B, exceeding operating income due to a net increase in non-operating income and expenses, as dividend income and interest income exceeded interest expense. Extraordinary income was limited to a ¥0.02B gain on the sale of investment securities, resulting in a limited impact on net income of ¥5.69B. The net profit margin improved significantly from the prior year to 11.6%, indicating growth in both revenue and profit.

Segment Analysis

The Machine segment was the primary contributor to company-wide profit, with revenue of ¥46.09B (YoY +45.4%), operating income of ¥8.75B (YoY +112.4%), and a profit margin of 19.0%. AutoMachine contracted, with revenue of ¥3.04B (YoY -33.5%) and operating income of ¥0.74B (YoY -26.3%), but maintained a high margin of 24.3%, exceeding that of Machine. Machine makes the larger contribution to company-wide profit, resulting in a business portfolio heavily weighted toward Machine.

Key Financial Indicators

【Profitability】The operating margin of 16.4% and net profit margin of 11.6% both improved significantly from the same period last year, primarily due to the improvement in gross margin to 31.7% and the decline in the SG&A ratio to 15.3%.【Cash Flow Quality】Accounts receivable of ¥35.52B and inventories of ¥12.09B increased alongside revenue growth, suggesting that working capital may be growing ahead of profit. 【Investment Efficiency】ROE was 3.5% (on a quarterly basis), primarily due to the improvement in net profit margin, while total asset turnover remained low. 【Financial Soundness】The equity ratio was high at 66.3%, and the capital structure was conservative, with cash and deposits of ¥42.49B compared with long-term borrowings of ¥21.98B.

Cash Flow Analysis

As no explicit cash flow statement data is available, cash flow trends are analyzed based on changes in the balance sheet. Cash and deposits were ¥42.49B, a decrease of ¥0.35B from the prior year, while accounts receivable of ¥35.52B and inventories of ¥12.09B increased, suggesting that the buildup of working capital accompanying revenue growth absorbed cash. Accounts payable also increased to ¥11.74B, indicating increased use of funds on the payment side. Long-term borrowings declined slightly to ¥21.98B, indicating limited reliance on debt financing. Overall, working capital is expanding faster than profit, suggesting that attention is warranted regarding the timing of cash generation.

Quality of Earnings

Recurring earnings account for the majority of profit, while extraordinary income consisted of only a ¥0.02B gain on the sale of investment securities, which was immaterial relative to net income; the impact of one-off factors was therefore limited. Non-operating income was ¥0.37B, only approximately 0.7% of revenue, and consisted primarily of dividend income of ¥0.15B and other non-operating income of ¥0.15B, indicating a stable composition. Non-operating expenses consisted primarily of interest expense of ¥0.12B, making the interest burden immaterial. The difference between ordinary income of ¥8.24B and operating income of ¥8.03B was small at +¥0.21B, indicating good structural earnings quality. However, comprehensive income of ¥10.21B exceeded net income of ¥5.69B, as increases in the valuation difference on securities of ¥3.54B and foreign currency translation adjustments of ¥1.04B boosted other comprehensive income. It is therefore important to note that, in addition to the earnings power of the core business, favorable market conditions expanded shareholders’ equity.

Earnings Forecast and Guidance

Progress against the full-year plan was 25.4% for revenue at ¥49.11B/¥193.0B, 28.2% for operating income at ¥8.03B/¥28.50B, and 28.9% for ordinary income at ¥8.24B/¥28.50B. All exceeded the standard Q1 progress rate of 25%, and the fact that progress on profit-related indicators exceeded revenue progress indicates that profitability improvements are proceeding beyond the assumptions incorporated into the plan. Against the full-year forecast of revenue YoY +22.2% and operating income YoY +45.1%, the current period is progressing at a pace exceeding those forecasts.

Shareholder Returns

The company forecasts an annual dividend of ¥112 per share. This represents a planned increase from the dividend of ¥32 in the same period last year (part of the interim or year-end dividend), indicating an upward direction for dividends. Based on approximately 66.83 million issued shares (excluding treasury shares; average during the period), the estimated total annual dividend is approximately ¥7.48B, resulting in an estimated payout ratio of 39.4% against the company’s net income plan of ¥19.0B. Given the financial base of an equity ratio of 66.3% and cash and deposits of ¥42.49B, there appear to be no significant constraints on securing funds for dividends.

Risk Factors

1. Segment concentration risk: The Machine segment accounts for 93.8% of revenue (¥46.09B/¥49.11B), creating a structure in which demand fluctuations in a single segment directly affect company-wide performance.

2. Working capital expansion risk: Accounts receivable of ¥35.52B and inventories of ¥12.09B have increased at a pace exceeding revenue growth (YoY +35.5%), creating the possibility of delays in cash conversion.

3. Foreign exchange and interest rate risk: Non-operating income and expenses include foreign exchange gains of ¥0.00B and interest expense of ¥0.12B, while foreign currency translation adjustments affected comprehensive income by ¥1.04B. Future market fluctuations may affect non-operating income and expenses and shareholders’ equity.

Industry Benchmark (For Reference; Compiled by the Company)

Industry Benchmark (manufacturing)

Profitability and Returns

Both the operating margin and net profit margin significantly exceed the industry median, placing the company’s profitability among the highest in the industry.

Growth and Capital Efficiency

The revenue growth rate significantly exceeds the industry median, demonstrating standout growth within the industry.

※Source: Compiled by the Company

Key Takeaways from the Earnings

1. The operating margin of 16.4% improved significantly from the same period last year and exceeded the industry median of 8.7% by 7.7pt. The simultaneous improvement in gross margin and decline in the SG&A ratio suggests a structural improvement in the profitability trend.

2. Progress against the full-year plan was 28.2% for operating income and 29.9% for net income, exceeding the standard progress rate of 25%. The faster progress of profit-related indicators than revenue at 25.4% provides evidence of the sustainability of profitability improvements.

3. Accounts receivable and inventories are increasing at a pace exceeding revenue growth, making working capital trends an important monitoring point when evaluating earnings quality.

Theoretical Share Price (Reference Value)

Sensitivity: ¥2,530–¥2,677 at ±1% for the cost of equity, and ¥2,597–¥2,609 at ±0.1 for ω.

Notes:

• Net assets as of the end of the quarter are used (there is a timing difference from the full-year forecast).
• As net assets include non-controlling interests, the theoretical value may be calculated somewhat higher.

(Valuation model: Residual Income Model (Ohlson-type, explicit 5-year fade) / Interest rate reference month: 2026-07 / Mechanically calculated solely from publicly disclosed data; this is not a forecast of the market share price or a recommendation of any specific investment action, and does not predict or guarantee future share prices.)

---

This report is an earnings analysis document automatically generated by AI through analysis of XBRL earnings summary data. It does not recommend investment in any specific security. The industry benchmarks are reference information compiled by the company based on publicly disclosed earnings data. Investment decisions should be made at your own discretion and responsibility, and after consulting a professional advisor as necessary.

---End of Report---

---

AI Financial Analysis

Executive Summary

CKD delivered a very strong FY2027 Q1 result, led by exceptional profit growth in its Equipment segment and substantial consolidated margin expansion. Revenue rose 35.5% year on year to ¥49.11bn. Operating income more than doubled, increasing 112.9% to ¥8.03bn. Ordinary income increased 122.5% to ¥8.24bn, while net income rose 129.5% to ¥5.69bn. The operating margin expanded by 600bp year on year to 16.4%, moving above the 15% threshold generally associated with excellent profitability. Gross margin increased by 260bp to 31.7%, indicating that the earnings acceleration was not solely volume-driven. Net margin improved by 480bp to 11.6%, supported by operating leverage and a modest net non-operating income contribution. SG&A increased only 11.2%, materially below revenue growth, demonstrating strong fixed-cost absorption. The Equipment segment was the principal earnings engine, with revenue up 45.4% to ¥46.07bn and segment profit up 112.4% to ¥8.75bn. Conversely, the Automatic Machinery segment saw revenue decline 33.5% to ¥3.04bn and segment profit decrease 26.3% to ¥0.74bn. Despite this weakness, the Equipment segment's scale and margin improvement more than offset the decline in Automatic Machinery. Annualized ROE was 14.2%, which is solid and close to the 15% excellent-profitability benchmark. The balance sheet remains conservatively funded, with a 311.9% current ratio, 0.51x debt-to-equity ratio, and cash equal to 8.29x short-term loans. However, working-capital efficiency is a key area for monitoring, as DSO of 66 days, DIO of 161 days, and an annualized cash-conversion cycle of 195 days are elevated. Q1 progress against full-year guidance is ahead of the standard seasonal pace, with sales at 25.4% and operating income at 28.2% of forecast. The revised full-year dividend forecast of ¥112 per share implies a dividend payout ratio of approximately 39.4%, which appears supportable by forecast earnings. The central forward issue is whether Equipment segment profitability can remain elevated while Automatic Machinery demand recovers and working-capital intensity is contained.

Profitability Analysis

Annualized ROE of 14.2% is decomposed into a net profit margin of 11.6%, annualized asset turnover of 0.812x, and financial leverage of 1.51x. The main driver of the return profile is profitability rather than leverage: CKD generates a double-digit net margin while maintaining moderate balance-sheet leverage. The largest year-on-year operating change was margin expansion, with gross margin improving to 31.7% from approximately 29.1% and operating margin rising to 16.4% from approximately 10.4%. This reflects favorable operating leverage, as revenue grew 35.5% while SG&A grew only 11.2%. The Equipment segment was the core business by operating-income contribution, producing ¥8.75bn of segment profit, or the overwhelming majority of total segment profit before corporate-cost allocation. Its segment margin expanded to 19.0% from 13.0% in the prior-year quarter. Automatic Machinery segment profit margin also improved, to 24.3% from 22.0%, but its revenue contraction reduced absolute profit contribution. The consolidated operating result includes ¥1.46bn of unallocated corporate costs, including administrative costs, long-term basic research, and CKD Global Service-related expenses. The five-factor decomposition shows a tax burden of 0.688 and an interest burden of 1.029, the latter reflecting net non-operating income relative to EBIT rather than debt stress. Interest coverage of 64.26x confirms that financing costs are immaterial to current earnings capacity. Dividend income of ¥0.15bn and interest income of ¥0.05bn supported non-operating income, while interest expense was only ¥0.13bn. The ¥0.19bn gain on sale of securities was small at about 0.3% of net income, so reported profit was predominantly operating in nature. The sustainability of the current margin level depends principally on Equipment segment volume, product mix, manufacturing utilization, and the ability to preserve disciplined SG&A growth.

Growth Assessment

Revenue growth was broad enough at the consolidated level to lift sales by ¥12.86bn year on year, but segment trends were highly divergent. Equipment segment external sales increased by ¥14.39bn to ¥46.07bn, more than accounting for consolidated growth. Automatic Machinery external sales decreased by ¥1.53bn to ¥3.04bn, making its recovery important for a more balanced growth profile. Equipment segment profit increased by ¥4.63bn, substantially exceeding the ¥0.26bn decline in Automatic Machinery profit. The strong incremental profitability in Equipment suggests operating leverage from higher production and shipment volumes. Consolidated gross profit grew 47.6%, faster than revenue, confirming improved gross-profit conversion. Operating income grew 112.9%, substantially faster than gross profit, due to overhead absorption and controlled SG&A. Full-year guidance calls for revenue of ¥193.0bn, up 22.2% year on year, and operating income of ¥28.5bn, up 45.1%. Q1 revenue progress of 25.4% is broadly in line with the 25% standard pace. Operating-income progress of 28.2%, ordinary-income progress of 28.9%, and net-income progress of 29.9% are each 3-5 percentage points ahead of the standard Q1 pace. This favorable start provides a buffer, although it also implies that the full-year forecast assumes moderation from the exceptionally strong first-quarter earnings rate. The major earnings-quality feature is that the improvement is primarily operational, rather than dependent on extraordinary gains or financial income.

Financial Health

CKD's financial position is strong. Current assets of ¥154.52bn exceeded current liabilities of ¥49.53bn, resulting in working capital of ¥104.99bn and a current ratio of 311.9%. The quick ratio was also robust at 287.5%, indicating that liquidity remains ample even before reliance on inventory realization. Cash and deposits totaled ¥42.49bn, compared with short-term loans of ¥5.12bn. Cash therefore covered short-term loans by 8.29x. Interest-bearing debt totaled ¥27.10bn, consisting primarily of ¥21.98bn in long-term loans, with only 18.9% classified as short-term debt. This liability structure limits near-term refinancing and maturity-mismatch risk. Debt-to-equity was a conservative 0.51x, while debt-to-capital was 14.4%, both well below levels associated with aggressive financial risk. Total equity rose 4.5% year on year to ¥160.47bn, and the equity ratio was 66.3%. Total liabilities increased 11.3% to ¥81.45bn, but the change did not materially weaken the capital structure. Interest coverage of 64.26x indicates substantial debt-servicing capacity. Non-current provisions were immaterial, while the net defined-benefit liability was ¥0.63bn. The principal balance-sheet consideration is not solvency but capital tied up in receivables and inventory.

Notable B/S Changes

Investments and other assets: +¥5.20bn (+24.4%) year on year to ¥26.51bn - higher investment exposure increases sensitivity of comprehensive income and equity to market valuation changes. Electronically recorded monetary claims: +¥2.78bn (+22.9%) year on year to ¥14.94bn - reinforces the increase in capital committed to customer receivables and is relevant to the elevated 66-day DSO. Accounts payable: +¥1.97bn (+20.1%) year on year to ¥11.74bn - supplier financing expanded, but the implied payment period remains insufficient to offset elevated receivable and inventory days. Other comprehensive income accumulated in equity: +¥4.52bn (+22.4%) year on year to ¥24.74bn - equity benefited from valuation and translation movements, particularly securities valuation gains and foreign-currency translation adjustments. Total liabilities: +¥8.27bn (+11.3%) year on year to ¥81.45bn - liabilities grew faster than assets, although stable loan balances and strong liquidity preserve a conservative solvency profile.

Cash Flow Quality

The available operating working-capital indicators point to a relatively long cash-conversion profile despite the strong accounting earnings result. The annualized DSO of 66 days triggers the HIGH_RECEIVABLE_DAYS alert because it exceeds the 60-day warning threshold. The root cause is a receivables balance of ¥35.53bn, supplemented by ¥14.94bn of electronically recorded monetary claims, relative to the annualized sales run rate. For a manufacturing company, 66 days is slower than the sub-45-day efficiency benchmark and may reflect extended customer payment terms, shipment timing, or slower collection in portions of the customer base. The impact is that a larger share of reported revenue remains uncollected at quarter-end, increasing funding requirements and potentially reducing cash conversion if sustained. The annualized DIO of 161 days also triggers the HIGH_INVENTORY_DAYS alert and is substantially above the 90-day warning threshold. The root cause is elevated inventory committed across the production cycle, including reported finished goods of ¥12.09bn, work in process of ¥5.36bn, and raw-material holdings disclosed at ¥41.78bn. In manufacturing, a 161-day inventory cycle raises the risk of slower inventory turns, working-capital absorption, and potential exposure to demand or product-mix changes. The annualized cash-conversion cycle of 195 days triggers the LONG_CCC alert because it exceeds the 120-day warning level. This reflects the combination of 66-day receivables, 161-day inventory, and an implied supplier-financing period of roughly 32 days. The long cycle is especially relevant because revenue growth is rapid; sustained growth can consume liquidity even when margins are high. The company has sufficient liquidity to absorb this working-capital requirement at present, but improvements in collection speed, inventory rotation, and production planning would strengthen cash conversion materially.

Dividend Sustainability

The full-year dividend forecast is ¥112 per share. Against forecast EPS of ¥284.29, the implied dividend payout ratio is approximately 39.4%. This is below the 60% sustainability benchmark and leaves meaningful earnings retention for capacity investment, working capital, debt reduction, and strategic investment. Forecast net income of ¥19.0bn provides substantial accounting coverage for the indicated dividend. The conservative 0.51x debt-to-equity ratio and large liquidity buffer further support financial flexibility. Dividend sustainability should nevertheless be assessed alongside the elevated working-capital cycle, because a prolonged 195-day annualized cash-conversion cycle can increase the cash needed to support operating growth. No share repurchase amount is indicated, so the analysis refers to the dividend payout ratio rather than a total return ratio.

Risk Assessment

Business risks include Automatic Machinery segment revenue declined 33.5% year on year to ¥3.04bn, and segment profit declined 26.3% to ¥0.74bn. A prolonged recovery delay would leave consolidated growth increasingly dependent on the Equipment segment., The Equipment segment generated ¥46.07bn of revenue and ¥8.75bn of segment profit, making earnings concentration a material risk if customer capital spending, factory-automation demand, semiconductor-related investment, or industrial production conditions soften., Manufacturing-specific risks include raw-material and component cost inflation, supply-chain disruption, quality-related costs, and demand volatility across industrial end markets., The ¥0.02bn net foreign-exchange gain was immaterial in Q1, but overseas manufacturing and sales activities can still expose earnings to currency movements and changes in export competitiveness..

Financial risks include HIGH_RECEIVABLE_DAYS: Annualized DSO of 66 days exceeds the 60-day warning threshold. Slow collection increases the capital tied up in sales and could weaken cash conversion if customer payment behavior deteriorates., HIGH_INVENTORY_DAYS: Annualized DIO of 161 days is well above the 90-day warning threshold. The level heightens the risk of inventory accumulation, slower turns, and valuation pressure if demand or product specifications change., LONG_CCC: The annualized 195-day cash-conversion cycle exceeds the 120-day warning threshold. This increases liquidity needs during growth periods and makes operational cash conversion more sensitive to shipment and collection timing., Comprehensive income of ¥10.21bn exceeded net income of ¥5.69bn, supported by ¥4.52bn of other comprehensive income, including valuation and foreign-currency translation effects. These valuation-related movements support book equity but are less directly distributable than recurring operating profit..

Key concerns include Whether the Equipment segment can sustain its 19.0% segment margin after the Q1 operating-leverage benefit., Whether Automatic Machinery can return to growth and reduce the concentration of earnings in Equipment., Whether receivable collection and inventory turnover improve sufficiently to shorten the annualized 195-day cash-conversion cycle., Whether the company can achieve its increased full-year plan while preserving gross-margin gains and SG&A discipline..

Investment Implications

Key takeaways include Q1 operating income of ¥8.03bn was 28.2% of the ¥28.5bn full-year forecast, ahead of the standard 25% Q1 progress rate., Operating margin expanded 600bp year on year to 16.4%, driven by gross-margin improvement and favorable SG&A leverage., Equipment is the core earnings contributor, with revenue growth of 45.4% and segment-profit growth of 112.4%., The balance sheet is conservative, with a 311.9% current ratio, 0.51x debt-to-equity, and 64.26x interest coverage., Working-capital efficiency is the principal financial issue, as annualized DSO, DIO, and CCC are 66 days, 161 days, and 195 days, respectively., The ¥112 forecast dividend implies a moderate 39.4% payout ratio based on forecast EPS..

Metrics to watch include Equipment segment revenue growth and segment margin, Automatic Machinery order recovery, sales growth, and segment profit, Consolidated gross margin and SG&A-to-sales trend, Annualized receivable days, inventory days, and cash-conversion cycle, Progress versus ¥193.0bn revenue, ¥28.5bn operating income, and ¥19.0bn net-income guidance, Inventory levels relative to end-market demand and production activity.

Regarding relative positioning, CKD currently presents a high-profitability, conservatively financed manufacturing profile: its 16.4% operating margin, 11.6% net margin, and 14.2% annualized ROE are strong, while leverage and interest burden remain low. Relative to typical industrial manufacturers, the major offset is a materially longer working-capital cycle, which makes execution on collections and inventory management central to the durability of earnings and cash generation.